Background A safe and efficacious vaccine against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of …

Background The ChAdOx1 nCoV-19 (AZD1222) vaccine has been approved for emergency
use by the UK regulatory authority, Medicines and Healthcare products Regulatory Agency, …

Sepsis is a leading cause of mortality in critically ill patients. Delay in diagnosis and initiation
of antibiotics have been shown to increase mortality in this cohort. However, differentiating …

Background The management of complex orthopedic infections usually includes a prolonged
course of intravenous antibiotic agents. We investigated whether oral antibiotic therapy is …

Infections related to implantable cardiac electronic devices (ICEDs), including pacemakers,
implantable cardiac defibrillators and cardiac resynchronization therapy devices, are …

Objectives Staphylococcus aureus bacteraemia is a common, often fatal infection. Our aim
was to describe how its clinical presentation varies between populations and to identify …

In this Journal, Zhu et al. recently reported the results of their genomic analysis of multidrug-resistant
Klebsiella pneumoniae isolates from individual patients before and after colistin …

Background: The performance of CURB65 in predicting mortality in community-acquired
pneumonia (CAP) has been tested in two large observational studies. However, it has not been …

Background Staphylococcus aureus bacteraemia is a common cause of severe community-acquired
and hospital-acquired infection worldwide. We tested the hypothesis that adjunctive …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of an ongoing
international outbreak of respiratory illness, known as coronavirus disease 2019 (COVID-19)…